Financial News

Financial Report: Sanofi

Genzyme sales up 17% in the quarter to $1.5 billion; completes acquisition of Boehringer CHC business

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi 4Q Revenues: €8.7 billion (-2%) 4Q Earnings: €159 million (-80%) FY Revenues:  €35.1 billion (+4%) FY Earnings: €8.6 billion (+78%) Comments: Pharmaceutical sales were up 3% in the quarter to €7.3 billion. Rare Disease sales increased 8% to €726 million. Genzyme sales were up 17% to $1.5 billion driven by contribution from new immunology franchise. Myozyme/ Lumizyme sales were $205 million in the quarter, up 12%. Cerezyme and Cerdelga sales were up 9% to €216 million supported by add...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters